Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ASCO 1998: A Commentary.

Chabner1, Friedberg

  • 1Massachusetts General Hospital and Dana-Farber/Partners Cancer Care, Boston, Massachusetts, 02114, USA. chabner.bruce@mgh.harvard.edu

The Oncologist
|July 1, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Faradisation in Asphyxia from Chloroform.

The American journal of dental science·2019
Same author

About sorrow

The oncologist·2000
Same author

Recombinant in vitro tools to predict drug metabolism and safety.

Pharmaceutical science & technology today·2000
Same author

Promising New Drugs and Combinations. Fulfilling Our Pledge.

The oncologist·1999
Same author

Virus infections of the eye.

Reviews in medical virology·1999
Same author

Schwartz Center Rounds. A Staff Dialogue on Phase I Trials: Psychosocial Issues Faced by Patients, Their Families, and Caregivers.

The oncologist·1999
Same journal

Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 population.

The oncologist·2026
Same journal

Molecular Tumor Board-Guided Osimertinib Therapy in EGFR L858R/Q701L-Mutant Lung Adenocarcinoma Supported by Functional Validation.

The oncologist·2026
Same journal

Phase 2 Dose Expansion Trial of OBI-3424, a DNA-Alkylating Prodrug, in Patients with Advanced Solid Tumors Expressing AKR1C3.

The oncologist·2026
Same journal

Divergent Biology and Outcomes of Somatic Transformations in Germ Cell Tumors.

The oncologist·2026
Same journal

Modernizing Disease Assessment in Prostate Cancer Trials: The Prostate Cancer Working Group 4 Framework.

The oncologist·2026
Same journal

Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial.

The oncologist·2026
See all related articles

The American Society of Clinical Oncology (ASCO) annual meeting highlights evolving cancer care, balancing clinical research with practical and financial aspects. The event featured outstanding scientific sessions and fostered professional reflection.

Area of Science:

  • Oncology
  • Medical Professional Societies

Background:

  • The American Society of Clinical Oncology (ASCO) is a pivotal organization for cancer specialists.
  • The annual ASCO meeting serves as a key event for professional networking and reflection.

Purpose of the Study:

  • To review the key aspects and outcomes of the recent American Society of Clinical Oncology (ASCO) annual meeting.
  • To assess the evolving role of ASCO in cancer care, research, and practice management.

Main Methods:

  • The review is based on the program and observed activities during the four-day ASCO meeting in Los Angeles.
  • Analysis of the integration of clinical research, financial, and organizational topics in the meeting agenda.

Main Results:

  • The meeting was well-organized, informative, and engaging, led by President Robert Mayer and Program Chair Margaret Shipp.

Related Experiment Videos

  • While clinical research remains central, there was a notable increase in focus on the financial and organizational aspects of cancer care.
  • The scientific sessions were of outstanding quality, despite the prominent presence of pharmaceutical companies.

    • Conclusions:

    • ASCO is an evolving organization that successfully balances its core mission of clinical research with the growing importance of practical and financial considerations in cancer care.
    • The meeting provided valuable scientific insights and opportunities for professional engagement within the oncology community.